Related Experiment Videos
Ampicillin may aggravate clinical and experimental myasthenia gravis
Archives of Neurology
|March 1, 1986
Abstract:
Ampicillin trihydrate aggravated the symptoms of two myasthenic patients. One patient had severe temporary weakness after an ampicillin sodium challenge. Ampicillin increased the preexisting electrical decrement in three rabbits with experimental autoimmune myasthenia gravis while the drug had no deleterious effects in less affected or normal animals. Myasthenic patients receiving ampicillin should be closely monitored for possible acute exacerbations.
Insights
Ampicillin can worsen symptoms in myasthenia gravis patients, causing severe weakness. Careful monitoring is crucial for myasthenic individuals prescribed ampicillin to prevent exacerbations.
Area of Science:
- Neurology
- Pharmacology
Background:
- Myasthenia gravis is an autoimmune disorder affecting neuromuscular junctions.
- Antibiotics are commonly prescribed, but their effects on myasthenia gravis are not fully understood.
Observation:
- Two myasthenia gravis patients experienced aggravated symptoms upon ampicillin administration.
- One patient developed significant temporary weakness after an ampicillin sodium challenge.
Findings:
- Ampicillin exacerbated electrophysiological deficits in rabbits with experimental autoimmune myasthenia gravis.
- The drug did not adversely affect less affected or normal animals, suggesting a specific interaction with the myasthenic condition.
Implications:
- Clinicians should exercise caution when prescribing ampicillin to myasthenia gravis patients.
- Close patient monitoring for potential acute exacerbations is recommended during ampicillin treatment.